{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:24:59Z","timestamp":1781648699214,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["20\/1819"],"award-info":[{"award-number":["20\/1819"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinejcf.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cardfail.2025.03.014","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T09:07:56Z","timestamp":1745312876000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS)"],"prefix":"10.1016","author":[{"given":"Giuseppe M.C.","family":"Rosano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Bayes-Genis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrien E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anekwe","family":"Onwuanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2025.03.014_bib0001","article-title":"Principles of Diagnosis and Treatment in Heart Affections","author":"MacKenzie","year":"1918","journal-title":"London: Henry Frowde and Hodder & Stoughton"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0002","doi-asserted-by":"crossref","unstructured":"Konstam M. A. Abboud F. M. Ejection fraction: Misunderstood and overrated (changing the paradigm in categorizing heart failure) Circulation 2017 135 8 717 719 10.1161\/CIRCULATIONAHA.116.025795","DOI":"10.1161\/CIRCULATIONAHA.116.025795"},{"issue":"4","key":"10.1016\/j.cardfail.2025.03.014_bib0003","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"issue":"5","key":"10.1016\/j.cardfail.2025.03.014_bib0004","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"Haakenson C A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.cardfail.2025.03.014_bib0005","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cardfail.2025.03.014_bib0006","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9149(90)90842-O","article-title":"Studies of Left Ventricular Dysfunction (SOLVD) \u2013 rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction","volume":"66","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0007","author":"McMurray","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032257","article-title":"Usefulness of heart failure categories based on left ventricular ejection fraction","author":"Christersson","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"35","key":"10.1016\/j.cardfail.2025.03.014_bib0009","article-title":"Cardiovascular magnetic resonance imaging and heart failure","volume":"23","author":"Liu","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0010","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ejhf.1961","article-title":"Cardiac magnetic resonance in heart failure with preserved ejection fraction: Myocyte, interstitium, microvascular, and metabolic abnormalities","volume":"22","author":"Quarta","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0011","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s10554-022-02618-8","article-title":"The variability of 2D and 3D transthoracic echocardiography applied in a general population: Intermodality, inter- and intraobserver variability","volume":"38","author":"Lyng Lindgren","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0012","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10554-023-02796-z","article-title":"La Brunner- Rocca HP PsychEcho Study Group A graphical analysis of aspects contributing to the spreading of measurements of left ventricular function","volume":"39","author":"Knackstedt","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0013","doi-asserted-by":"crossref","unstructured":"Yuan N, Jain I, Rattehalli N, He B, Pollick C, Liang D, Heidenreich P, Zou J, Cheng S, Ouyang D, Systematic quantification of sources of variation in ejection fraction calculation using deep learning JACC Cardiovasc Imaging 2021 14 2260 2262 10.1016\/j.jcmg.2021.06.018","DOI":"10.1016\/j.jcmg.2021.06.018"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0014","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1456","article-title":"Oh JK Variability in ejection fraction measured by echocardiography, gated single-photon emission computed tomography, and cardiac magnetic resonance in patients with coronary artery disease and left ventricular dysfunction","volume":"1","author":"Pellikka","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"77","key":"10.1016\/j.cardfail.2025.03.014_bib0016","first-page":"84","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: Application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0017","doi-asserted-by":"crossref","unstructured":"Medvedofsky D Maffessanti F Weinert L Tehrani DM Narang A Addetia K Mediratta A Besser SA Maor E Patel AR Spencer KT Mor-Avi V Lang RM 2D and 3D echocardiography-derived indices of left ventricular function and shape: Relationship with mortality JACC Cardiovasc Imaging 2018 11 1569 1579 10.1016\/j.jcmg.2017.08.023","DOI":"10.1016\/j.jcmg.2017.08.023"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0018","doi-asserted-by":"crossref","unstructured":"Wood PW, Choy JB, Nanda NC, Becher H, Left ventricular ejection fraction and volumes: It depends on the imaging method Echocardiography 2014 31 87 100 10.1111\/echo.12331","DOI":"10.1111\/echo.12331"},{"issue":"98","key":"10.1016\/j.cardfail.2025.03.014_bib0019","first-page":"106","article-title":"Left ventricular volume measurement with echocardiography: A comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging","volume":"30","author":"Jenkins","year":"2009","journal-title":"Eur Heart J"},{"issue":"762","key":"10.1016\/j.cardfail.2025.03.014_bib0020","first-page":"776","article-title":"The use of biplane angiocardigraphy for the measurement of left ventricular volume in man","volume":"60","author":"Dodge","year":"1960","journal-title":"Am Heart J"},{"issue":"260","key":"10.1016\/j.cardfail.2025.03.014_bib0021","first-page":"274","article-title":"Assessment of left ventricular function by echocardiography: The case for routinely adding global longitudinal strain to ejection fraction","volume":"11","author":"Potter","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"287","key":"10.1016\/j.cardfail.2025.03.014_bib0022","first-page":"294","article-title":"Myocardial strain in the assessment of patients with heart failure: A review","volume":"4","author":"Marwick","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.cardfail.2025.03.014_bib0023","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.3036","article-title":"Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC","volume":"25","author":"Bayes-Genis","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.cardfail.2025.03.014_bib0024","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.cardfail.2025.03.014_bib0025","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1253\/circj.CJ-21-0431","article-title":"JCS\/JHFS 2021 Guideline focused update on diagnosis and treatment of acute and chronic heart failure","volume":"85","author":"Tsutsui","year":"2021","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.cardfail.2025.03.014_bib0026","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ejhf.2161","article-title":"NEDA Investigators Change in ejection fraction and long-term mortality in adults referred for echocardiography","volume":"23","author":"Strange","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.cardfail.2025.03.014_bib0027","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchf.2018.11.019","article-title":"Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure","volume":"7","author":"Savarese","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.cardfail.2025.03.014_bib0028","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction \u2013 a report from the CHART-2 study","volume":"19","author":"Tsuji","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.cardfail.2025.03.014_bib0029","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.cardfail.2025.03.014_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003875","article-title":"Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: A nationwide cohort study","volume":"10","author":"Vedin","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.03.014_bib0031","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.cardfail.2025.03.014_bib0032","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug","year":"2011","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.cardfail.2025.03.014_bib0033","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: An individual patient data meta-analysis","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.cardfail.2025.03.014_bib0034","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0735-1097(03)00789-7","article-title":"The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure","volume":"42","author":"Curtis","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.03.014_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ejhf.2695","article-title":"Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction","volume":"25","author":"van Essen","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.cardfail.2025.03.014_bib0036","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ejhf.2895","article-title":"Prevalence, characteristics and cardiovascular and non-cardiovascular outcomes in patients with heart failure with supra-normal ejection fraction: Insight from the JROADHF study","volume":"25","author":"Horiuchi","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.cardfail.2025.03.014_bib0037","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/eurheartj\/ehz550","article-title":"Fornwalt BK Routinely reported ejection fraction and mortality in clinical practice: Where does the nadir of risk lie?","volume":"41","author":"Wehner","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.cardfail.2025.03.014_bib0038","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ejhf.2843","article-title":"Ventricular stiffening and chamber contracture in heart failure with higher ejection fraction","volume":"25","author":"Popovic","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.cardfail.2025.03.014_bib0039","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.1776","article-title":"Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure","volume":"22","author":"Dewan","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.cardfail.2025.03.014_bib0040","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/ejhf.2482","article-title":"Do R Genetic and phenotypic profiling of supranormal ejection fraction reveals decreased survival and underdiagnosed heart failure","volume":"24","author":"Forrest","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0041","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.1149","article-title":"Heart failure with mid-range ejection fraction in CHARM: Characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum","volume":"20","author":"Lund","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0042","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1388-9842(99)00039-2","article-title":"Perindopril for elderly people with chronic heart failure: The PEP-CHF study. The PEP Investigators","volume":"1","author":"Cleland","year":"1999","journal-title":"Eur J Heart Fail"},{"issue":"993","key":"10.1016\/j.cardfail.2025.03.014_bib0043","first-page":"1004","article-title":"PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"215","key":"10.1016\/j.cardfail.2025.03.014_bib0044","first-page":"225","article-title":"SENIORS Investigators Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0045","article-title":"Cardiac contractility modulation device implantation for heart failure. Interventional procedures guidance","volume":"655","year":"2019","journal-title":"IPG"},{"issue":"819","key":"10.1016\/j.cardfail.2025.03.014_bib0046","first-page":"829","article-title":"Brueckmann Martina Ofstad Anne Pernille Pfarr Egon Jamal Waheed Packer Milton SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"2885","key":"10.1016\/j.cardfail.2025.03.014_bib0047","first-page":"2896","article-title":"Cleland JGF Beta-Blockers in Heart Failure Collaborative Group Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure","volume":"69","author":"Kotecha","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cardfail.2025.03.014_bib0048","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1253\/circj.CJ-13-0187","article-title":"TEND Investigators Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry)","volume":"77","author":"Sato","year":"2013","journal-title":"Circ J"},{"issue":"1609","key":"10.1016\/j.cardfail.2025.03.014_bib0049","first-page":"1620","article-title":"Lefkowitz MP PARAGON-HF Investigators and Committees Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0050","doi-asserted-by":"crossref","unstructured":"Solomon SD, Vaduganathan M, Claggett BL, Packer M, Zile M, Swedberg K, Rouleau J, Pfeffer MA, Desai A, Lund LH, Kober L, Anand I, Sweitzer N, Linssen G, Merkely B, Arango Luis J, Vinereanu D, Chen CH, Senni M, Sibulo A, Boytsov S, Shi V, Rizkala A, Lefkowitz M, McMurray JJV, Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure Circulation 2020 141 352 361. doi: 10.1161\/CIRCULATIONAHA.119.044586","DOI":"10.1161\/CIRCULATIONAHA.119.044586"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0063","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"issue":"1995","key":"10.1016\/j.cardfail.2025.03.014_bib0051","first-page":"2008","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"1413","key":"10.1016\/j.cardfail.2025.03.014_bib0052","first-page":"1424","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Anker","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0053","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0054","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.122.059785","article-title":"Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes","volume":"146","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"issue":"1089","key":"10.1016\/j.cardfail.2025.03.014_bib0055","first-page":"1098","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0056","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: A comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"issue":"117","key":"10.1016\/j.cardfail.2025.03.014_bib0057","first-page":"128","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.cardfail.2025.03.014_bib0058","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"FINEARTS-HF Committees and Investigators Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"issue":"10458","key":"10.1016\/j.cardfail.2025.03.014_bib0059","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: An individual patient level meta-analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet"},{"issue":"487","key":"10.1016\/j.cardfail.2025.03.014_bib0060","first-page":"496","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction","volume":"3","author":"Abraham","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.cardfail.2025.03.014_bib0061","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex activation therapy in patients with heart failure with reduced ejection fraction","volume":"76","author":"Zile","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.03.014_bib0062","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T01:58:11Z","timestamp":1745632691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":63,"alternative-id":["S1071916425001538"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.03.014","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Cardiology, The Heart Failure Society of America, and The Japanese Heart Failure Society. Published by Elsevier Inc and by John Wiley & Sons Limited.","name":"copyright","label":"Copyright"}]}}